Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, 24 Week Parallel-group Placebo-controlled (Phase 2) Pilot-study of High Dose Omega 3 (DHA) in People at Risk for Dementia

NCT03926351 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT03926351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03926351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, 24 Week Parallel-group Placebo-controlled (Phase 2) Pilot-study of High Dose Omega 3 (DHA) in People at Risk for Dementia
Lead sponsor
University Hospital, Akershus
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2018
Completion date
October 31, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain diseases, central nervous system diseases, cognition disorders, cognitive decline, cognitive dysfunction, dementia, inflammation, mental disorder, mild cognitive impairment, nervous system diseases, neurocognitive disorders, pathologic processes, scd